Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

FDA grants approval for Taltz as treatment of active ankylosing spondylitis

Aug. 27, 2019

Medshine Discovery identifies Janus kinase inhibitors

Aug. 23, 2019

Identifying the cause of lupus cognitive dysfunction

Aug. 22, 2019

Placental growth factor may be autoimmune disease target

Aug. 22, 2019

PI3K-alpha tested as a therapeutic target for prevention of heterotopic ossification

Aug. 21, 2019

FDA approves Rinvoq for the treatment of moderate to severe rheumatoid arthritis

Aug. 19, 2019

Fast skeletal muscle troponin activators can counter skeletal muscle fatigue

Aug. 16, 2019

Pharmacological stabilization of TYK2 kinase could treat multiple immune-mediated diseases

Aug. 14, 2019

Good news, bad news macrophages identified in arthritis

Aug. 13, 2019

FDA approves Turalio as first therapy for rare and debilitating joint tumor

Aug. 5, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
Insilico Medicine synthesizes new Nav1.8 blockers
BioWorld Science
Insilico Medicine Inc. has identified sodium channel protein type 10 subunit α (SCN10A; Nav1.8) blockers that are potentially useful for the treatment of pain.